Pharmaceutical applications of chitosan

Abstract Considerable research efforts have been directed towards the development of safe and efficient chitosan-based drug delivery systems. In this review, the authors outline the major new approaches to the pharmaceutical applications of chitosan and discuss its mechanisms of action in various in vitro and in vivo models.

[1]  A. Martínez-Palomo,et al.  Occluding junctions and cytoskeletal components in a cultured transporting epithelium , 1980, The Journal of cell biology.

[2]  K. P. Rao,et al.  Collagen-chitosan composite membranes for controlled release of propranolol hydrochloride , 1995 .

[3]  Tsutomu Suzuki,et al.  Chitosan Capsules for Colon-Specific Drug Delivery: Improvement of Insulin Absorption from the Rat Colon , 1997 .

[4]  H. Junginger,et al.  Chitosans for enhanced delivery of therapeutic peptides across intestinal epithelia: in vitro evaluation in Caco-2 cell monolayers , 1997 .

[5]  H. Seo,et al.  Antibacterial and Antifungal Fiber Blended by Chitosan , 1992 .

[6]  Y. Ohya,et al.  Possibility of application of quaternary chitosan having pendant galactose residues as gene delivery tool , 1996 .

[7]  Claus-Michael Lehr,et al.  In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers , 1992 .

[8]  G. Golomb,et al.  Preparation and evaluation of chitosan microspheres containing bisphosphonates. , 1997, Journal of drug targeting.

[9]  R. Friend,et al.  Structural and photophysical investigations of polyacetylene prepared by different precursor routes , 1994 .

[10]  J. Lowe,et al.  Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers. , 1997, Journal of pharmaceutical sciences.

[11]  A. Jayakrishnan,et al.  Cross-linked chitosan microspheres as carriers for prolonged delivery of macromolecular drugs. , 1994, Journal of biomaterials science. Polymer edition.

[12]  A. Rolland,et al.  Controllable gene therapy pharmaceutics of non-viral gene delivery systems , 1996 .

[13]  M. Itoh,et al.  Occludin: a novel integral membrane protein localizing at tight junctions , 1993, The Journal of cell biology.

[14]  H. Seo,et al.  Effect of multiporous microspheres derived from chitin and partially deacetylated chitin on the activation of mouse peritoneal macrophages. , 1987, Vaccine.

[15]  M. Alonso,et al.  Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers , 1997 .

[16]  P. Sado,et al.  Ophthalmic drug delivery systems—Recent advances , 1998, Progress in Retinal and Eye Research.

[17]  C. G. Pitt,et al.  The controlled parenteral delivery of polypeptides and proteins , 1990 .

[18]  Gerrit Borchard,et al.  The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro , 1996 .

[19]  E. Adickes,et al.  Chitosan Effect in Vascular Surgery, Tissue Culture and Tissue Regeneration , 1986 .

[20]  C. Yomota,et al.  [Sustained-release effect of the direct compressed tablet based on chitosan and Na alginate]. , 1994, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[21]  R. Muzzarelli.  Natural chelating polymers : alginic acid, chitin, and chitosan , 1973 .

[22]  L. Illum,et al.  The effect of chronic nasal application of chitosan solutions on cilia beat frequency in guinea pigs , 1997 .

[23]  J. Kristl,et al.  Hydrocolloids and gels of chitosan as drug carriers , 1993 .

[24]  J. Siliciano,et al.  Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia , 1986, The Journal of cell biology.

[25]  F. Lim,et al.  Microencapsulated islets as bioartificial endocrine pancreas. , 1980, Science.

[26]  M. Weiner.  An Overview of the Regulatory Status and of the Safety of Chitin and Chitosan as Food and Pharmaceutical Ingredients , 1992 .

[27]  M. Alonso,et al.  Design of microencapsulated chitosan microspheres for colonic drug delivery. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[28]  Y. Takatsuka,et al.  Mechanisms for the enhancement of the nasal absorption of insulin by surfactants , 1981 .

[29]  S. Hirano,et al.  Chitosan: A Biocompatible Material for Oral and Intravenous Administrations , 1990 .

[30]  L. Block,et al.  Use of chitosan in compressed tablets of diclofenac sodium: inhibition of drug release in an acidic environment. , 1997, Pharmaceutical development and technology.

[31]  S. Yoshikawa,et al.  Highly deacetylated chitosan and its properties , 1983 .

[32]  O Skaugrud,et al.  Metal recovery using chitosan. , 2007, Journal of chemical technology and biotechnology.

[33]  O. Smidsrod,et al.  Degradation of fully water-soluble, partially N-acetylated chitosans with lysozyme , 1994 .

[34]  R. Woodman,et al.  Selective aggregation of L1210 leukemia cells by the polycation chitosan. , 1971, Journal of the National Cancer Institute.

[35]  Roland Bodmeier,et al.  Mechanical, water uptake and permeability properties of crosslinked chitosan glutamate and alginate films , 1997 .

[36]  A. Jayakrishnan,et al.  Cross‐linked Chitosan Microspheres: Preparation and Evaluation as a Matrix for the Controlled Release of Pharmaceuticals , 1992, The Journal of pharmacy and pharmacology.

[37]  T. Ouchi,et al.  Design of Chitosan-5Fu Conjugate Exhibiting Antitumor Activity , 1991 .

[38]  H. Junginger,et al.  Mucoadhesive polymers in peroral peptide drug delivery. IV. Polycarbophil and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitro , 1997 .

[39]  P. Lacy,et al.  Protection of Encapsulated Human Islets Implanted Without Immunosuppression in Patients With Type I or Type II Diabetes and in Nondiabetic Control Subjects , 1994, Diabetes.

[40]  Y. Ohya,et al.  Design of quaternary chitosan conjugate having antennary galactose residues as a gene delivery tool , 1997 .

[41]  R. Muzzarelli,et al.  Reconstruction of parodontal tissue with chitosan. , 1989, Biomaterials.

[42]  P. Perugini,et al.  Bioadhesive Microspheres for Ophthalmic Administration of Acyclovir , 1997, The Journal of pharmacy and pharmacology.

[43]  G. Skjåk‐Braek,et al.  An immunologic basis for the fibrotic reaction to implanted microcapsules. , 1991, Transplantation proceedings.